Our Insights Oncology, R&D Insights Anthony Iannacci 11/11/25 Oncology, R&D Insights Anthony Iannacci 11/11/25 How Equinox Group Models Drugs in R&D: The Case of Alecensa in 1L ALK+ NSCLC Read More Oncology, R&D Insights Anthony Iannacci 8/26/20 Oncology, R&D Insights Anthony Iannacci 8/26/20 Comparing Opportunity Across Subpopulations: Rozlytrek as a Case Study Read More Want to get in touch? Click here
Oncology, R&D Insights Anthony Iannacci 11/11/25 Oncology, R&D Insights Anthony Iannacci 11/11/25 How Equinox Group Models Drugs in R&D: The Case of Alecensa in 1L ALK+ NSCLC Read More
Oncology, R&D Insights Anthony Iannacci 8/26/20 Oncology, R&D Insights Anthony Iannacci 8/26/20 Comparing Opportunity Across Subpopulations: Rozlytrek as a Case Study Read More
